Spike (S) Protein
Rabbit Anti-human Cathepsin S IgG |
|||
CTHS23-A | Alpha Diagnostics | 100 ul | EUR 489.6 |
Human IgG antibody Laboratories manufactures the spike (s) protein reagents distributed by Genprice. The Spike (S) Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Spike products are available in stock. Specificity: Spike Category: (S) Group: Protein
True north Cryobox 15mLNatural |
||
Scientific Laboratory Supplies | PK10 | EUR 212.4 |
True north Cryobox 15mLBlue |
||
Scientific Laboratory Supplies | PK10 | EUR 212.4 |
True north Cryobox 50mLNatural |
||
Scientific Laboratory Supplies | PK10 | EUR 210 |
True north Cryobox 50mLBlue |
||
Scientific Laboratory Supplies | PK10 | EUR 210 |
True north Cryobox1.5/2mLNatural |
||
Scientific Laboratory Supplies | PK10 | EUR 162 |
True north Cryobox1.5/2.0mLGreen |
||
Scientific Laboratory Supplies | PK10 | EUR 162 |
Human true insulin,TI ELISA Kit |
||
SunredBio | 96 tests | EUR 528 |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
MERS-CoV Spike protein (aa 367-606) [Fc] |
|||
DAG-H10302 | Creative Diagnostics | 20µg | EUR 868.8 |
COVID-19 Spike Protein a.a. 800 to 1000 |
|||
00222-V-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: COVID-19 Spike Protein a.a. 800 to 1000 |
Recombinant SARS Spike Mosaic S Protein (aa 12-53, 90-115, 171-203) |
|||
VAng-Lsx0055-inquire | Creative Biolabs | inquire | Ask for price |
Description: Recombinant SARS-CoV Spike protein containing 12-53, 90-115, 171-203 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. |
Recombinant SARS Spike Mosaic S Protein (aa 1051-1076, 1121-1154, 1162-1190) |
|||
VAng-Lsx0057-inquire | Creative Biolabs | inquire | Ask for price |
Description: Recombinant SARS-CoV Spike protein containing 1051-1076, 1121-1154, 1162-1190 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. |
MERS-CoV Spike protein (aa 1-1297) [His] |
|||
DAG-H10300 | Creative Diagnostics | 20µg | EUR 868.8 |
MERS-CoV Spike Protein (aa 367-606) [His] |
|||
DAGB201 | Creative Diagnostics | 20 µg | EUR 868.8 |
MERS Spike S1 Recombinant protein |
|||
39-102 | ProSci | 0.1 mg | EUR 556.8 |
Description: Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom, France, Italy, Greece, Germany, the Netherlands, Austria, Tunisia, Egypt, Malaysia, Turkey and the United States of America. Coronaviruses are the cause of the common cold, SARS (severe acute respiratory syndrome) and other severe illnesses with high mortality rates, all are classified into coronavirus family. MERS-CoV is a new type of SARS found in the coronavirus family causing severe pneumonia with sudden and serious respiratory illness with high mortality rates as well. Since January 27th 2015, the WHO has reported 956 human cases, including 351 deaths. More cases of the new coronavirus strain are expected. Like in other coronaviruses, large surface spike glycoprotein is a central structural protein of this virus; it is located above the virion surface to bind and enter into the target cell. Spike protein has 2 domains- S1 and S2. The S1 domain is responsible for cellular tropism and interaction with target cell, while the S2 domain is responsible for membrane fusion. The C-terminal of S1 domain contains a receptor binding domain, and is also a potential target for vaccine development and an antigen for diagnosis. |
Recombinant SARS Spike Protein (aa 1-1190) [His] |
|||
VAng-Lsx0063-inquire | Creative Biolabs | inquire | Ask for price |
Description: SARS Spike protein (aa 1-1190) [His], recombinant protein from HEK 293 cells. |
SARS-CoV-2 (COVID-19) Trimeric Spike (S) Recombinant Protein Liquid |
|||
ICOV2TRISTR100UG | Innovative research | each | EUR 1215 |
Description: SARS-CoV-2 (COVID-19) Trimeric Spike (S) Recombinant Protein Liquid |
Bovine coronavirus Spike glycoprotein (S) |
|||
1-CSB-EP333052BJO | Cusabio |
|
|
Description: Recombinant Bovine coronavirus Spike glycoprotein(S) ,partial expressed in E.coli |
Bovine coronavirus Spike glycoprotein (S) |
|||
1-CSB-YP333052BJO | Cusabio |
|
|
Description: Recombinant Bovine coronavirus Spike glycoprotein(S),partial expressed in Yeast |
Bovine coronavirus Spike glycoprotein (S) |
|||
1-CSB-EP322803BJK | Cusabio |
|
|
Description: Recombinant Bovine coronavirus Spike glycoprotein(S),partial expressed in E.coli |
2019 nCoV/COVID19 RBD domain of spike recombinant protein (S)- Fc tag |
|||
BSV-COV-PR-44 | BioServUK | 100 ug | Ask for price |
Description: 2019 nCoV/COVID19 RBD domain of spike recombinant protein (S)- Fc tag (100 ug) |
2019 nCoV/COVID19 RBD domain of spike recombinant protein (S)- Fc tag |
|||
BSV-COV-PR-45 | BioServUK | 500 ug | Ask for price |
Description: 2019 nCoV/COVID19 RBD domain of spike recombinant protein (S)- Fc tag (500 ug) |
COVID-19 Spike S1 protein a.a. 1 to 800 |
|||
00226-V-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: COVID-19 Spike S1 protein a.a. 1 to 800 |
MERS-CoV Spike protein S2 (aa 726-1296) [His] |
|||
DAG-H10296 | Creative Diagnostics | 20µg | EUR 868.8 |
MERS-CoV Spike protein S1 (aa 1-725) [His] |
|||
DAG-H10298 | Creative Diagnostics | 20µg | EUR 868.8 |